Since its inception, Windgap Medical has been
revolutionizing drug delivery devices and the medicine they contain to create simple, safe, and stable solutions for today’s most concerning health conditions. With 85+
issued patents, Windgap seeks to improve the lives of patients with life-threatening allergies, diabetes, opioid addiction, cyanide exposure, and more through its partnerships with ALK Abelló, University of Minnesota Twin Cities, National Institutes of Health, Allergy Partners, Molex, and more. Windgap Medical is based out of Watertown, Massachusetts, a growing pharmaceutical hub in the US.
